Literatuurreferenties
1. IB-tekst Niaspan® via: www.cbg-meb.nl, Geneesmiddeleninformatiebank.
2. Morgan JM, et al. Treatment effects of niaspan, a controlled-release Niacin, in patients with hypercholesterolemia: a placebo-controlled trial. J Cardiovasc Pharmacol Ther 1996; 212: 195-202.
3. Guyton JR, et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Arch Intern Med 2000; 160: 1177-1184.
4. Goldberg AC. Clinical trial experience with extended-release Niacin (Niaspan): dose-escalation study. Am J Cardiology 1998; 82: 35U-38U.
5. Knopp RH, et al. Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism 1998; 47: 1097-1104.
6. Hunninghake DB, et al. A dose-ranging study of a new, once-daily, dual component drug product containing niacin extended-release and lovastatin. Clin Cardiol 2003; 6: 112-118.
